As assessed by the LH/FSH ratio of plasma hormones, only rats in the EC500 treatment group exhibited a response in the LH/FSH ratio, unlike the corresponding rats with PCOS (Figure 3C). The gene discussed is BRD2; the disease is polycystic ovary syndrome.